These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 386157)

  • 21. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W; Novick AC; Stowe N; Magnusson M; Straffon RA
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
    Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW
    N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor pretreatment in cardiac allografts.
    Nowygrod R; Hardy MA; Todd GJ; Oluwole S; Reemtsma K
    Transplant Proc; 1979 Jun; 11(2):1462-4. PubMed ID: 382540
    [No Abstract]   [Full Text] [Related]  

  • 24. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cadaver Kidney transplantation. Effect of hypotension and donor pretreatment with methylprednisolone and phenoxybenzamine.
    Toledo-Pereyra LH; Simmons RL; Olson LC; Najarian JS
    Minn Med; 1979 Mar; 62(3):159-61. PubMed ID: 370540
    [No Abstract]   [Full Text] [Related]  

  • 26. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.
    Schnuelle P; Lorenz D; Mueller A; Trede M; Van Der Woude FJ
    Kidney Int; 1999 Aug; 56(2):738-46. PubMed ID: 10432416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.
    McCabe R; Swistel A; Lorieo D; Fitzpatrick HF
    Transplant Proc; 1980 Jun; 12(2):355-7. PubMed ID: 6156529
    [No Abstract]   [Full Text] [Related]  

  • 28. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor pretreatment with cyclophosphamide and methylprednisolone.
    Brom HL; van Breda Vriesman PJ
    Transplantation; 1983 Jul; 36(1):106-7. PubMed ID: 6408773
    [No Abstract]   [Full Text] [Related]  

  • 30. A study on the mechanism of donor pretreatment: effect of procarbazine hydrochloride and methylprednisolone in immunocompetent cells.
    van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J
    Transplantation; 1981 Jul; 32(1):24-8. PubMed ID: 7022795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manipulation of allograft immunogenicity by pretreatment of cadaver donors.
    Guttmann RD
    Urol Clin North Am; 1976 Oct; 3(3):475-90. PubMed ID: 790729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression and rehabilitation following cadaveric renal transplantation. New developments.
    Guttmann RD; Beaudoin JG; Gonda A; Gorman P
    Urology; 1973 Feb; 1(2):102-7. PubMed ID: 4589225
    [No Abstract]   [Full Text] [Related]  

  • 34. Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival.
    Langhoff E; Ladefoged J; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thaysen JH
    Lancet; 1986 Jun; 1(8493):1296-7. PubMed ID: 2872430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of sex on kidney transplants.
    Shibue T; Kondo K; Iwaki Y; Terasaki PI
    Clin Transpl; 1987; ():351-60. PubMed ID: 3154434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of transfusions and donor pretreatment on canine renal allograft survival.
    van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H
    J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term cadaver allograft survival in the recipient with a positive B lymphocyte crossmatch.
    Ettenger RB; Uittenbogaart CH; Pennisi AJ; Malekzadeh MH; Fine RN
    Transplantation; 1979 May; 27(5):315-8. PubMed ID: 373188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
    Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
    J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of donor age on outcome of kidney transplantation. A two-year analysis of transplants reported to the United Network for Organ Sharing Registry.
    Alexander JW; Bennett LE; Breen TJ
    Transplantation; 1994 Mar; 57(6):871-6. PubMed ID: 8154034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.